Cargando…
Tislelizumab for squamous lung cancer combined with basal cell carcinoma of the skin: A case report
Surgery is the preferred treatment for basal cell carcinoma (BCC), locally advanced or metastatic BCC, radiation therapy or systemic therapy can be considered. Programmed death receptor 1 (PD-1) inhibitors are rarely used to treat cutaneous BCC. In the present case, we found that tislelizumab, a PD-...
Autores principales: | Wu, Ming-Jun, Chen, Yu-Chun, Cui, Xiao-Li, Yang, Qian, Xue, Qing-Liang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10174383/ https://www.ncbi.nlm.nih.gov/pubmed/37171300 http://dx.doi.org/10.1097/MD.0000000000033788 |
Ejemplares similares
-
Efficacy and safety of two different adjuvant chemotherapy regimens in combination with concurrent chemoradiotherapy in treating patients with advanced nasopharyngeal carcinoma: A protocol for randomized controlled trial
por: Zhang, Lu-Lu, et al.
Publicado: (2021) -
Clinical efficacy and safety of nazartinib for epidermal growth factor receptor mutated non-small cell lung cancer: Study protocol for a prospective, multicenter, open-label
por: Cui, Jun, et al.
Publicado: (2021) -
Combination Therapy of Metformin and Statin May Decrease Hepatocellular Carcinoma Among Diabetic Patients in Asia
por: Chen, Hsin-Hung, et al.
Publicado: (2016) -
Efficacy and safety of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitor versus chemotherapy for advanced lung cancer: A meta-analysis
por: Zhang, Pei-Pei, et al.
Publicado: (2021) -
Comparative efficacy and safety of sunitinib vs sorafenib in renal cell carcinoma: A systematic review and meta-analysis
por: Liu, Xiu-Lan, et al.
Publicado: (2020)